CDC logo
Safer Healthier People
CDC Home CDC Search CDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Skip navigation links Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us

Search for NIOSH Publications: NIOSHTIC-2

NIOSHTIC-2 Search Results

      Advanced Search  |  Help  |  About  |  Feedback 
Terms: 20024456
1 - 1 of 1 Bibliographic entries
All record(s) shown.
Save All   |   Save Page
View Saved    |    Download
Select check boxes to automatically save entries, or use 'save all' or 'save page' links above.

In vivo sensitization to purified Hevea brasiliensis proteins in health care workers sensitized to natural rubber latex.
Authors
Bernstein-DI; Biagini-RE; Karnani-R; Hamilton-R; Murphy-K; Bernstein-C; Arif-SA; Berendts-B; Yeang-HY
Source
J Allergy Clin Immunol 2003 Mar; 111(3):610-616
Link
http://dx.doi.org/10.1067/mai.2003.164 
NIOSHTIC No.
20024456 
Abstract
BACKGROUND: Thirteen proteins of natural rubber latex (Hevea brasiliensis) known to bind human IgE have been isolated and characterized as Hev b allergens. However, the in vivo importance of native Hev b allergens has not been defined in health care workers (HCWs) with natural rubber latex (NRL) allergy. OBJECTIVES: The principal aim of this study was to identify the major in vivo Hev b allergens in HCWs with NRL allergy confirmed by percutaneous sensitivity to nonammoniated latex (NAL). METHODS: Skin prick testing was performed with 7 (native) proteins purified from NAL (Hev b 1, 2, 3, 4, 6.01, 7.01, and a newly described Hev b 13) and recombinant Hev b 5 in 62 HCWs with histories of NRL allergy (group 1) confirmed by percutaneous reactivity to NAL and in 49 atopic HCWs without NRL allergy (group 2). Serial 10-fold concentrations of Hev b proteins (5 x 10(-5) microg/mL to 50 microg/mL) were tested; serum samples of subjects were assayed for serum specific IgE by immunoassays. RESULTS: Hev b 2, Hev b 5, Hev b 6.01, and Hev b 13 produced skin reactions in more than 60% of group 1 subjects, with Hev b 1, 3, 4, and 7.01 eliciting reactions in less than 50%. Only 1 of 49 group 2 workers reacted to a single Hev b antigen (Hev b 13). Specificity of 7 Hev b allergens was 100% and 98% for Hev b 13 in identifying workers with confirmed NRL allergy. Specific IgE by AlaSTAT and CAP immunoassays was elevated in 40 of 60 (67%) and 33 of 62 (53%) of NAL-reactive workers and produced false-positive test results in 4 of 49 (8%) and 3 of 48 (6%) group 2 subjects, respectively. CONCLUSION: Hev b 2, 5, and 6.01 are major in vivo allergens and Hev b 13 is a new major in vivo allergen among HCWs with allergy to NRL.
Keywords
Allergens; Allergies; Allergic-dermatitis; Allergic-reactions; Health-care-personnel; Nurses; Doctors; Medical-personnel
Page 1 of 1
All record(s) shown.

File Formats Help:

Adobe PDF file
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?double arrows.